Neuropsychiatric Aspects of Infectious Diseases

Fleishman, 2001, Trends in HIV-related inpatient admissions from 1993–1997: a seven-state study, J Acquir Immune Defic Syndr, 28, 73, 10.1097/00042560-200109010-00011 Fleishman, 2003, Recent trends in HIV-related inpatient admissions 1996–2000: a seven-state study, J Acquir Immune Defic Syndr, 34, 102, 10.1097/00126334-200309010-00015 Paul, 2002, Impact of antiretroviral therapy on decreasing hospitalization rates of HI-infected patients in 2001, AIDS Res Hum Retroviruses, 18, 501, 10.1089/088922202317406646 Cebo, 2003, Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy, J Acquir Immune Defic Syndr, 27, 143 Ferrando, 2006, HIV disease, 277 Perry, 1984, Psychiatric problems of aids inpatients at the New York Hospital: preliminary report, Public Health Rep, 99, 200 Dilley, 1985, Findings in psychiatric consultations with patients with acquired immune deficiency syndrome, Am J Psychiatry, 142, 82, 10.1176/ajp.142.1.82 O'Dowd, 1990, AIDS patients compared with others seen in psychiatric consultation, Gen Hosp Psychiatry, 12, 50, 10.1016/0163-8343(90)90038-E Bialer, 1996, Psychiatric comorbidity among hospitalized AIDS patients vs. non-AIDS patients referred for psychiatric consultation, Psychosomatics, 37, 469, 10.1016/S0033-3182(96)71535-9 Ferrando, 1998, Psychiatric disorders and adjustment of HIV and AIDS patients during and after medical hospitalization, Psychosomatics, 39, 214 1991, American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type-1 (HIV-1) infection, Neurology, 41, 778, 10.1212/WNL.41.6.778 Antinori, 2007, Updated research nosology for HIV-associated neurocognitive disorders, Neurology, 69, 1789, 10.1212/01.WNL.0000287431.88658.8b Sacktor, 1996, Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death, J Neurovirol, 2, 404, 10.3109/13550289609146906 Wilkie, 1998, Mild cognitive impairment and risk of mortality in HIV-1 infection, J Neuropsychiatry Clin Neurosci, 10, 125, 10.1176/jnp.10.2.125 Tozzi, 2005, Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART, AIDS Res Hum Retroviruses, 21, 706, 10.1089/aid.2005.21.706 Anthony, 2008, The neuropathology of AIDS, Int Rev Psychiatry, 20, 15, 10.1080/09540260701862037 Smit, 2004, Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment, J Virol, 78, 10133, 10.1128/JVI.78.18.10133-10148.2004 Letendre, 2008, Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system, Arch Neurol, 65, 65, 10.1001/archneurol.2007.31 Sacktor, 2001, HIV-associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990-1998, Neurology, 56, 257, 10.1212/WNL.56.2.257 Filippi, 1998, Regression of HIV encephalopathy and basal ganglia signal intensity abnormality at MR imaging in patients with AIDS after the initiation of protease inhibitor therapy, Radiology, 206, 491, 10.1148/radiology.206.2.9457204 Sacktor, 2005, A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia, J Magn Reson Imaging, 21, 325, 10.1002/jmri.20272 Tozzi, 1999, Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment, AIDS, 13, 1889, 10.1097/00002030-199910010-00011 Ferrando, 2003, Longitudinal improvement in psychomotor processing speed is associated with potent combination antiretroviral therapy in HIV-1 infection, J Neuropsychiatry Clin Neurosci, 15, 208, 10.1176/appi.neuropsych.15.2.208 Ferrando, 1998, Highly active antiretroviral treatment (HAART) in HIV infection: benefits for neuropsychological function, AIDS, 12, F65, 10.1097/00002030-199808000-00002 Robertson, 2007, The Prevalence and incidence of neurocognitive impairment in the HAART era, AIDS, 21, 1915, 10.1097/QAD.0b013e32828e4e27 Hinkin, 2004, Medication adherence in HIV-infected adults: effect of patient age, cognitive status and substance abuse, AIDS, 18, S19, 10.1097/00002030-200418001-00004 van Gorp, 2007, Neuropsychiatric predictors of return to work in HIV/AIDS, J Int Neuropsychol Soc, 13, 80, 10.1017/S1355617707070117 Perry, 1990, Psychiatric diagnosis before serological testing for the human immunodeficiency virus, Am J Psychiatry, 147, 89, 10.1176/ajp.147.1.89 Williams, 1991, Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection II. Standardized clinical assessment of current and lifetime psychopathology, Arch Gen Psychiatry, 48, 124, 10.1001/archpsyc.1991.01810260032005 Crone, 2003, Comprehensive review of hepatitis C for psychiatrists: risks, screening, diagnosis, treatment and interferon-based therapy complications, J Psychiatr Pract, 9, 93, 10.1097/00131746-200303000-00002 Maxwell, 1988, Manic syndrome associated with zidovudine treatment, JAMA, 259, 3406, 10.1001/jama.259.23.3406 Brouillette, 1994, Didanosine-induced mania in HIV infection, Am J Psychiatry, 151, 1839, 10.1176/ajp.151.12.1839b Foster, 2004, More on abacavir-induced neuropsychiatric reactions, AIDS, 18, 2449 Morlese, 2002, Nevirapine-induced neuropsychiatric complications, a class effect of non-nucleoside reverse transcriptase inhibitors?, AIDS, 16, 1840, 10.1097/00002030-200209060-00023 Staszewski, 1999, Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in treatment of HIV-1 infection in adults. Study 006 team, N Engl J Med, 341, 1865, 10.1056/NEJM199912163412501 Chen, 2005, Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease, Medicine (Baltimore), 84, 98, 10.1097/01.md.0000159082.45703.90 Mylonakis, 2001, Diagnosis and treatment of androgen deficiency in human immunodeficiency virus-infected men and women, Clin Infect Dis, 33, 857, 10.1086/322695 Mayo, 2002, Adrenal function in the human immunodeficiency virus-infected patient, Arch Intern Med, 162, 1095, 10.1001/archinte.162.10.1095 Mierlak, 1995, Does physical improvement reduce depressive symptoms in HIV-infected medical inpatients?, Gen Hosp Psychiatry, 17, 380, 10.1016/0163-8343(95)00052-S Rabkin, 1992, Depression, distress, lymphocyte subsets and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men, Arch Gen Psychiatry, 48, 111, 10.1001/archpsyc.1991.01810260019002 Ferrando, 1997, SSRI treatment of depression in symptomatic HIV infection and AIDS: improvements in affective and somatic symptoms, Gen Hosp Psychiatry, 19, 89, 10.1016/S0163-8343(96)00172-7 Holmes, 1989, Psychostimulant response in AIDS-related complex patients, J Clin Psychiatry, 50, 5 Wagner, 2000, Effects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind, placebo-controlled trial, J Clin Psychiatry, 61, 436, 10.4088/JCP.v61n0608 Breitbart, 2001, A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease, Arch Intern Med., 161, 411, 10.1001/archinte.161.3.411 Rabkin, 2004, Modafinil treatment of fatigue in HIV+ patients, J Clin Psychiatry, 65, 1688, 10.4088/JCP.v65n1215 Breitbart, 1996, A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients, Am J Psychiatry, 153, 231, 10.1176/ajp.153.2.231 Mijch, 1999, Secondary mania in patients with HIV infection: are antiretrovirals protective?, J Neuropsychiatry Clin Neurosci, 11, 475, 10.1176/jnp.11.4.475 Tanquary, 1993, Lithium neurotoxicity at therapeutic levels in an AIDS patient, J Nerv Ment Dis., 181, 518, 10.1097/00005053-199308000-00009 Halman, 1993, Anticonvulsant use in the treatment of manic syndromes in patients with HIV-1 infection, J Neuropsychiatry Clin Neurosci, 5, 430, 10.1176/jnp.5.4.430 McDaniel, 2000, Practice guideline for the treatment of patients with HIV/AIDS, Am J Psychiatry, 157, 1 Sewell, 1994, HIV-associated psychosis: a study of 20 cases. San Diego HIV Neurobehavioral Research Center Group, Am J Psychiatry, 151, 237, 10.1176/ajp.151.2.237 Sewell, 1994, Neuroleptic treatment of HIV-associated psychosis. HNRC group, Neuropsychopharmacology, 10, 223, 10.1038/npp.1994.25 Fernandez, 1993, The use of molindone in the treatment of psychotic and delirious patients infected with the human immunodeficiency virus. Case reports, Gen Hosp Psychiatry, 15, 31, 10.1016/0163-8343(93)90088-6 Lera, 1999, Pilot study with clozapine in patients with HIV-associated psychosis and drug-induced parkinsonism, Mov Disord, 14, 128, 10.1002/1531-8257(199901)14:1<128::AID-MDS1021>3.0.CO;2-J Singh, 1997, Treatment of HIV-related psychotic disorders with risperidone: a series of 21 cases, J Psychosom Res, 42, 489, 10.1016/S0022-3999(96)00373-X Meyer, 1998, Differential sensitivities to risperidone and olanzapine in a human immunodeficiency virus patient, Biol Psychiatry, 44, 791, 10.1016/S0006-3223(97)00552-0 Arciniegas, 2004, Viral encephalitis: neuropsychiatric and neurobehavioral aspects, Curr Psychiatry Rep, 6, 372, 10.1007/s11920-004-0024-x Chaudhuri, 2002, Diagnosis and treatment of viral encephalitis, Postgrad Med J, 78, 575, 10.1136/pmj.78.924.575 Hjalmarsson, 2007, Herpes simplex encephalitis in Sweden, 1990-2001: incidence, morbidity and mortality, Clin Infect Dis, 45, 875, 10.1086/521262 Whitley, 2002, Viral encephalitis: familiar infections and emerging pathogens, Lancet, 359, 507, 10.1016/S0140-6736(02)07681-X Pavone, 2006, Autoimmune neuropsychiatric disorders associated with streptococcal infection: Sydenham's chorea, PANDAS, and PANDAS variants, J Child Neurol, 21, 727, 10.1177/08830738060210091401 Schneider, 2002, Psychiatric presentations of non-HIV infectious diseases: neurocysticercosis, Lyme disease, and pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection, Psychiatr Clin North Am, 25, 1, 10.1016/S0193-953X(03)00049-2 Swedo, 2002, Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS), Mol Psychiatry, 7, S24, 10.1038/sj.mp.4001170 Perlmutter, 1998, A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, Am J Psychiatry, 155, 1592, 10.1176/ajp.155.11.1592 Pavone, 2004, Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection, Pediatr Neurol, 30, 107, 10.1016/S0887-8994(03)00413-2 Giedd, 2000, MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection, Am J Psychiatry, 157, 281, 10.1176/appi.ajp.157.2.281 Perlmutter, 1999, Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood, Lancet, 354, 1153, 10.1016/S0140-6736(98)12297-3 Garvey, 1999, A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections, Biol Psychiatry, 45, 1564, 10.1016/S0006-3223(99)00020-7 Snider, 2005, Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders, Biol Psychiatry, 57, 788, 10.1016/j.biopsych.2004.12.035 Del Brutto, 2005, Neurocysticercosis, Semin Neurol, 25, 243, 10.1055/s-2005-917661 Tavares, 1993, Psychiatric disorders in neurocysticercosis, Br J Psychiatry, 163, 839, 10.1192/bjp.163.6.839a Meza, 2005, Cysticercosis in chronic psychiatric inpatients from a Venezuelan community, Am J Trop Med Hyg, 73, 504, 10.4269/ajtmh.2005.73.504 Signore, 1988, Acute psychosis in a patient with cerebral cysticercosis, Psychosomatics, 29, 106, 10.1016/S0033-3182(88)72429-9 Nash, 2006, Treatment of neurocysticercosis: current status and future research needs, Neurology, 67, 1120, 10.1212/01.wnl.0000238514.51747.3a Hutto, 2001, Syphilis in clinical psychiatry: a review, Psychosomatics, 46, 453, 10.1176/appi.psy.42.6.453 Conde-Sendín, 2004, Current clinical spectrum of neurosyphilis in immunocompetent patients, Eur Neurol., 52, 29, 10.1159/000079391 Sanchez, 2007, Treatment of psychiatric symptoms associated with neurosyphilis, Psychosomatics, 48, 440, 10.1176/appi.psy.48.5.440 Carmo, 2001, Syphilitic meningitis in HIV-patients with meningeal syndrome: report of two cases and review, Braz J Infect Dis, 5, 280, 10.1590/S1413-86702001000500007 Sobhan, 2004, Unusual case report: three cases of psychiatric manifestations of neurosyphilis, Psychiatr Serv, 55, 830, 10.1176/appi.ps.55.7.830 Russouw, 1997, Psychiatric manifestations and magnetic resonance imaging in HIV-negative neurosyphilis, Biol Psychiatry, 41, 467, 10.1016/S0006-3223(96)00060-1 Taycan, 2006, Quetiapine vs. risperidone in treating psychosis in neurosyphilis: a case report, Gen Hosp Psychiatry, 8, 359, 10.1016/j.genhosppsych.2006.02.006 Turan, 2007, Effectiveness of olanzapine in neurosyphilis related organic psychosis: a case report, J Psychopharmacol, 21, 556, 10.1177/0269881106071033 Martindale, 2003, Psychiatric and neuroimaging findings in Creutzfeldt-Jakob disease, Curr Psychiatry Rep, 5, 43, 10.1007/s11920-003-0008-2 Caramelli, 2006, Prion diseases: current understanding of epidemiology and pathogenesis and therapeutic advances, CNS Drugs, 20, 15, 10.2165/00023210-200620010-00002 Pederson, 2002, Prion diseases: epidemiology in man, APMIS, 110, 14, 10.1034/j.1600-0463.2002.100103.x Spencer, 2002, First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features, BMJ, 324, 1479, 10.1136/bmj.324.7352.1479 Wall, 2005, Psychiatric manifestations of Creutzfeldt-Jakob disease: a 25-year analysis, J Neuropsychiatry Clin Neurosci, 17, 489, 10.1176/appi.neuropsych.17.4.489 Moellentine, 1999, The varied neuropsychiatric presentations of Creutzfeldt-Jakob disease, Psychosomatics, 40, 260, 10.1016/S0033-3182(99)71244-2 Jiang, 1999, Sporadic Creutzfeldt-Jakob disease presenting as major depression, South Med J, 92, 807, 10.1097/00007611-199908000-00012 Jadri, 2006, Depressive disorder with psychotic symptoms as psychiatric presentation of sporadic Creutzfeldt-Jakob disease: a case report, Gen Hosp Psychiatry, 28, 452, 10.1016/j.genhosppsych.2006.05.005 Kapur, 2003, The neuropsychological profile associated with variant Creutzfeldt-Jakob disease, Brain, 126, 2693, 10.1093/brain/awg279 Wieser, 2006, EEG in Creutzfeldt-Jakob disease, Clin Neurophysiol, 117, 935, 10.1016/j.clinph.2005.12.007 Green, 2002, Use of 14-3-3 in the diagnosis of Creutzfeldt-Jacob disease, Biochem Soc Trans, 30, 382, 10.1042/bst0300382 Collinge, 2005, Molecular neurology of prion disease, J Neurol Neurosurg Psychiatry, 76, 906, 10.1136/jnnp.2004.048660 Kaplan, 2003, Cognitive function in post-treatment Lyme disease: do additional antibiotics help?, Neurology, 60, 1888, 10.1212/01.WNL.0000068030.26992.25 Kaplan, 1997, Lyme encephalopathy: a neuropsychological perspective, Semin Neurol, 17, 31, 10.1055/s-2008-1040910 Oksi, 1996, Inflammatory brain changes in Lyme borreliosis: a report on three patients and review of literature, Brain, 119, 2143, 10.1093/brain/119.6.2143 Logigian, 1997, Reversible cerebral hypoperfusion in Lyme encephalopathy, Neurology, 49, 1661, 10.1212/WNL.49.6.1661